Septic Arthritis

Disclaimer: This information is intended for educational purposes and as a clinical reference for healthcare professionals. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. Clinical judgment, patient-specific factors, and current local guidelines must always be considered. Always consult with a qualified healthcare provider for any health concerns or before making any decisions related to patient care.

Overview

• Definition: Septic arthritis, also known as infectious arthritis or pyogenic arthritis, is an acute inflammatory condition of a joint caused by direct invasion of the synovial space by microorganisms, most commonly bacteria. This leads to rapid inflammation, enzymatic destruction of cartilage, and potential bone damage, which can result in irreversible joint destruction if not promptly diagnosed and treated.
• Epidemiology:
  • Incidence: Approximately 2-10 cases per 100,000 person-years in the general population, but significantly higher in high-risk groups (e.g., intravenous drug users, prosthetic joint recipients, rheumatoid arthritis patients).
  • Demographics: Can occur at any age, but peaks in young children (especially <3 years) and older adults. Males are affected more commonly than females.
  • Joints Affected:
    • Native Joints: Most commonly monoarticular, with the knee being the most frequently affected joint (50-60%), followed by the hip (20%), shoulder (10-15%), ankle, wrist, and elbow. Sternoclavicular and sacroiliac joints are less common but can occur, especially in IV drug users.
    • Prosthetic Joints: Hip and knee prostheses are most common sites.
  • Microorganisms: Staphylococcus aureus is the most common causative organism in all age groups (40-60% of cases). Other common pathogens include streptococci (e.g., S. pyogenes, S. pneumoniae) and Gram-negative bacilli (e.g., E. coli, Pseudomonas aeruginosa, Neisseria gonorrhoeae). N. gonorrhoeae is a common cause in sexually active young adults.
• Classification:
  • By causative organism: Non-gonococcal (most common, often S. aureus) vs. Gonococcal (disseminated gonococcal infection).
  • By joint type: Native joint septic arthritis vs. Prosthetic joint infection (PJI). PJI has specific diagnostic criteria and management challenges.
  • By route of infection: Hematogenous (most common), direct inoculation (trauma, surgery, injection), contiguous spread (osteomyelitis, cellulitis).
  • By number of joints: Monoarticular (most common) vs. Polyarticular (e.g., in rheumatoid arthritis, disseminated gonococcal infection, or immunocompromised patients).

Pathophysiology

• Mechanism:
  1. Bacterial Entry: Microorganisms most commonly gain access to the joint space via hematogenous spread from a distant infection (e.g., skin, urinary tract, respiratory tract). Less commonly, direct inoculation occurs during trauma, surgery, arthroscopy, or intra-articular injections. Contiguous spread from adjacent osteomyelitis or cellulitis can also occur.
  2. Synovial Invasion: The synovium is highly vascular and lacks a limiting basement membrane, allowing bacteria to easily enter and multiply within the synovial fluid.
  3. Inflammatory Response: Bacteria trigger a robust inflammatory response. Synoviocytes, macrophages, and neutrophils are activated, releasing pro-inflammatory cytokines (e.g., TNF-α, IL-1, IL-6, IL-8), proteases, and reactive oxygen species.
  4. Joint Damage: This intense inflammatory cascade directly damages articular cartilage. Proteases (e.g., matrix metalloproteinases, elastase) degrade collagen and proteoglycans. Bacterial toxins also contribute to cartilage destruction. Increased intra-articular pressure due to effusion can also compromise blood supply to the cartilage and subchondral bone.
  5. Rapid Progression: Without prompt treatment, cartilage destruction can be rapid and irreversible, often within days. This can lead to fibrous or bony ankylosis, osteomyelitis, or sepsis.
• Risk Factors:
  • Pre-existing Joint Disease: Rheumatoid arthritis, osteoarthritis, gout, pseudogout (crystal-induced inflammation can predispose to bacterial superinfection). Prior joint damage or surgery.
  • Immunosuppression: Diabetes mellitus, chronic kidney disease, hepatic insufficiency, HIV/AIDS, malignancy, solid organ transplant recipients, chronic corticosteroid use, TNF-α inhibitors or other biologics.
  • Bacteremia Sources: Skin infections (cellulitis, abscesses), urinary tract infections, pneumonia, endocarditis, intravenous drug use (IVDU).
  • Joint Trauma/Procedures: Recent arthroscopy, intra-articular injections (corticosteroids, hyaluronic acid), joint aspiration, penetrating trauma, open wounds near a joint.
  • Prosthetic Joints: Significantly increased risk (0.5-2% lifetime risk following arthroplasty).
  • Age: Extremes of age (infants, elderly).
  • Other: Alcoholism, poor nutrition.
• Protective Factors:
  • Intact Immune System: Healthy immune response can prevent hematogenous spread or clear minor infections.
  • Healthy Skin Barrier: Prevents direct bacterial inoculation.
  • Good Hygiene: Reduces overall bacterial load and risk of skin/soft tissue infections.
  • Prompt Treatment of Infections: Early and effective treatment of distant infections (e.g., skin, UTI) can prevent hematogenous seeding.
  • Aseptic Technique: Strict adherence to aseptic technique during intra-articular injections or surgical procedures.

Clinical Presentation

Signs and Symptoms

• Cardinal Features: Typically acute onset (hours to days) of:
  • Severe Joint Pain: Often described as excruciating, worsened by movement or weight-bearing.
  • Joint Swelling: Due to effusion and synovial inflammation.
  • Warmth and Erythema: Overlying the affected joint.
  • Limited Range of Motion (ROM): Both active and passive ROM are significantly restricted due to pain and effusion. Pain is elicited at even minimal passive movement.
  • Fever: Present in ~80% of adults, often >38°C (100.4°F). May be absent in elderly or immunocompromised patients.
  • Constitutional Symptoms: Malaise, chills.
• Early Signs:
  • Localized joint pain and tenderness.
  • Slight swelling and warmth.
  • Mild restriction of movement.
  • Low-grade fever or absence of fever.
• Advanced Signs:
  • Marked joint effusion, severe pain.
  • Fluctuant swelling.
  • Overlying skin redness and severe warmth.
  • Inability to bear weight or move the joint.
  • High fever, rigors, signs of sepsis (hypotension, tachycardia, altered mental status).
  • Development of adjacent cellulitis or abscess.
• Atypical Presentations:
  • Polyarticular Septic Arthritis: Occurs in 10-20% of cases, more common in patients with pre-existing inflammatory arthritis (e.g., RA), disseminated gonococcal infection, or immunocompromised states. Can mimic a flare of the underlying arthritis.
  • Insidious Onset: Especially in children, elderly, or immunocompromised patients, symptoms may develop over weeks, mimicking osteomyelitis or aseptic arthritis.
  • Prosthetic Joint Infection (PJI): Can be acute (within 3 months of surgery) or chronic (months to years after surgery). Chronic PJI often presents with subtle pain, loosening of the prosthesis, or chronic drainage. Fever may be absent.
  • Neonates/Infants: May present with pseudoparalysis (child refusing to move limb), irritability, decreased feeding, or subtle swelling. Fever may be absent or low-grade. Hip joint commonly affected.
  • Drug Users/Immunocompromised: May have less typical joint involvement (e.g., sternoclavicular, sacroiliac, vertebral), multiple joint involvement, or polymicrobial infections.

Physical Examination

• Inspection:
  • Swelling: Visible effusion, often causing loss of normal joint contours. May be diffuse or localized.
  • Erythema: Redness of the overlying skin.
  • Position of Comfort: Patients often hold the joint in slight flexion to accommodate effusion and minimize pain.
  • Skin integrity: Look for puncture marks, cellulitis, or signs of distant infection.
• Palpation:
  • Warmth: Increased temperature over the joint compared to surrounding skin.
  • Tenderness: Exquisite tenderness to palpation directly over the joint line.
  • Effusion: Palpable fluid wave or bulge, particularly evident in the knee (patellar ballottement, bulge sign).
  • Fluctuance: May indicate an abscess.
• Special Tests:
  • Range of Motion (ROM): Severely restricted both actively and passively, with pain elicited even by minimal passive movement. Compare to the contralateral joint.
  • Weight-Bearing: Often impossible or extremely painful on the affected limb.
  • Hip Joint Specific: In infants, frog-leg position (flexed, abducted, externally rotated) is often adopted. Pain with passive internal rotation of the hip is a highly sensitive sign.
  • Spine: Tenderness over sacroiliac or sternoclavicular joints, pain with axial loading or specific maneuvers.

Diagnostic Approach

History Taking

• Key Questions:
  • Onset and Duration: Acute (hours-days) vs. subacute/chronic.
  • Nature of Pain: Severity, location, radiation, aggravating/alleviating factors.
  • Systemic Symptoms: Fever, chills, malaise, weight loss.
  • Joint Involvement: Monoarticular vs. polyarticular. Which joints are affected?
  • Recent Trauma/Procedures: Falls, injuries, joint injections, surgery, arthroscopy.
  • Risk Factors:
    • Comorbidities: Diabetes, rheumatoid arthritis, gout, HIV, renal failure, liver disease, malignancy.
    • Immunosuppression: Corticosteroids, biologics, chemotherapy.
    • Intravenous Drug Use (IVDU).
    • Sexual History: Risk for gonococcal infection (especially in young, sexually active individuals).
    • Prior Infections: Skin infections, UTIs, pneumonia, endocarditis.
    • Prosthetic Joints: Date of implantation, previous infections.
  • Medications: Especially antibiotics or immunosuppressants.
• Red Flags:
  • Acute, severe monoarticular pain, swelling, warmth, and restricted ROM (especially hip or knee).
  • Fever and systemic signs of infection.
  • Recent joint surgery or injection.
  • Immunocompromised status.
  • Presence of a prosthetic joint.
  • Inability to bear weight.
  • These warrant immediate arthrocentesis and empiric antibiotic therapy.

Laboratory Tests

• First-Line:
  • Synovial Fluid Analysis (from arthrocentesis): This is the most crucial diagnostic step and should be performed urgently.
    • Gross Appearance: Turbid, purulent, opaque, often yellowish or grayish.
    • Leukocyte Count: Typically >50,000 cells/mm³ (mean ~100,000 cells/mm³) with >75% polymorphonuclear neutrophils (PMNs). Values between 20,000-50,000 cells/mm³ are indeterminate and require careful interpretation in context. Lower counts can be seen in early infection, gonococcal arthritis, or immunocompromised patients.
    • Gram Stain: Positive in ~50-75% of non-gonococcal septic arthritis cases (higher for gram-positive cocci). Guides initial empiric antibiotic selection.
    • Culture and Sensitivity: Definitive diagnosis. Identifies the causative organism and its antibiotic susceptibility.
    • Glucose: Synovial fluid glucose <50% of serum glucose (or absolute value <40 mg/dL) due to bacterial consumption.
    • Protein: Elevated (>2.5 g/dL).
    • Lactate: Elevated synovial fluid lactate (>10 mmol/L) can support diagnosis, especially if culture is negative.
    • Crystal Analysis: Polarized light microscopy to rule out crystal-induced arthritis (gout, pseudogout), which can co-exist with septic arthritis.
  • Blood Tests:
    • Complete Blood Count (CBC): Leukocytosis with left shift (elevated white blood cell count, particularly neutrophils) is common, but can be normal or low in immunocompromised patients.
    • Erythrocyte Sedimentation Rate (ESR): Markedly elevated (>50 mm/hr, often >100 mm/hr).
    • C-Reactive Protein (CRP): Markedly elevated (>10 mg/L, often >100 mg/L). CRP tends to rise and fall more rapidly than ESR, making it useful for monitoring treatment response.
    • Blood Cultures: Should be drawn from at least two sites before initiating antibiotics. Positive in ~30-50% of non-gonococcal septic arthritis cases.
• Confirmatory:
  • Positive Synovial Fluid Culture: The gold standard for confirming bacterial septic arthritis.
  • Positive Gram Stain with Clinical Suspicion: Can guide empiric treatment while awaiting cultures.
• Monitoring:
  • ESR and CRP: Trends are useful for assessing response to treatment. Levels should decrease with effective therapy. Failure to normalize suggests inadequate drainage, incorrect antibiotic, or osteomyelitis.
  • Repeat Synovial Fluid Analysis: May be considered in selected cases if clinical response is poor, to confirm sterility after drainage, or to guide further management.
  • Wound/Drainage Cultures: If surgical drainage is performed.

Imaging

• Recommended:
  • Plain Radiographs (X-rays):
    • Initial: Often normal in the first few days. May show soft tissue swelling, joint effusions (e.g., distended joint capsule, widening of joint space), or displacement of fat pads.
    • Later: Can reveal signs of osteomyelitis, periarticular osteopenia, or joint space narrowing (indicating cartilage loss) after 7-10 days. Not useful for early diagnosis but can rule out other conditions (e.g., fracture) and establish baseline for tracking chronic changes.
  • Ultrasound:
    • Highly sensitive for detecting joint effusions, especially in non-palpable joints (e.g., hip, shoulder) or small joints. Can differentiate effusion from synovial thickening.
    • Useful for guiding diagnostic arthrocentesis or therapeutic aspiration.
    • Can identify loculated effusions or adjacent abscesses.
• Advanced:
  • Magnetic Resonance Imaging (MRI):
    • Most sensitive imaging modality for detecting early changes, including synovitis, cartilage damage, bone marrow edema (suggesting osteomyelitis), and periarticular soft tissue involvement.
    • Useful when diagnosis is uncertain, to assess for osteomyelitis, or to plan surgical debridement (e.g., hip, sacroiliac joint, or cases complicated by adjacent soft tissue abscesses).
    • Can differentiate septic arthritis from osteomyelitis, transient synovitis, or avascular necrosis.
  • Computed Tomography (CT):
    • Less sensitive for soft tissue and early bone marrow changes than MRI.
    • Useful for evaluating complex bony anatomy (e.g., sacroiliac joint, sternoclavicular joint, spine) and for surgical planning when severe bone destruction is suspected.
    • Can guide aspiration or biopsy in difficult-to-access joints.
  • Bone Scintigraphy (Technetium-99m):
    • Highly sensitive but not specific. May show increased uptake in areas of inflammation or infection.
    • Limited role due to better spatial resolution and specificity of MRI. May be useful in polyarticular disease or when other modalities are inconclusive.
  • Gallium-67 or Indium-111 Labeled Leukocyte Scintigraphy:
    • More specific for infection than bone scans, especially useful in distinguishing infection from inflammatory conditions in prosthetic joints. Often combined with bone scan.

Management

Acute Management

• Immediate (within hours):
  1. Joint Aspiration: Perform emergent diagnostic arthrocentesis. This is both diagnostic (for Gram stain, culture, cell count) and therapeutic (to decompress the joint and remove pus).
  2. Empiric Antibiotic Therapy: Start broad-spectrum intravenous (IV) antibiotics immediately after aspirating joint fluid and drawing blood cultures, without waiting for culture results. Delaying antibiotics significantly worsens prognosis.
     • Initial Choice (Non-gonococcal, Native Joint):
       • Empiric for Gram-positive coverage: Vancomycin (15-20 mg/kg IV every 8-12 hours, adjust for renal function, target trough 15-20 mcg/mL) for presumed MRSA, especially in areas with high MRSA prevalence, IVDU, or recent hospitalization/antibiotic exposure.
       • Empiric for Gram-negative coverage (often added for broader coverage):
         • 3rd generation cephalosporin (e.g., Ceftriaxone 2 g IV every 24 hours) or
         • Cefepime (2 g IV every 8-12 hours) if Pseudomonas is a concern (e.g., IVDU, neutropenic patients).
         • For neonates or very young children (<3 months), consider additional agents for Group B Strep and enteric gram-negatives (e.g., Ampicillin + Gentamicin/Cefotaxime).
       • Considerations:
         • Gram Stain Result: If Gram stain shows Gram-positive cocci, narrow coverage to vancomycin. If Gram-negative bacilli, narrow to a cephalosporin or carbapenem depending on local resistance. If no organisms seen, maintain broad coverage.
         • Risk Factors: Adjust based on risk factors (e.g., ceftazidime or cefepime for Pseudomonas if IVDU or penetrating injury, piperacillin-tazobactam if polymicrobial or anaerobes suspected).
         • Suspected Gonococcal Arthritis: Ceftriaxone 1 g IV every 24 hours (or Cefotaxime 1 g IV every 8 hours) plus a single dose of azithromycin 1 g PO (to cover co-infection with Chlamydia trachomatis).
  3. Pain Management: Provide adequate analgesia.
• Stabilization:
  • Joint Drainage: This is critical. Options include:
    • Serial Needle Aspiration: Preferred for most accessible native joints (e.g., knee). Performed daily or every other day until the synovial fluid cell count decreases significantly (<10,000-20,000 cells/mm³) and cultures are negative. Less invasive.
    • Arthroscopic Lavage and Debridement: Indicated for joints difficult to aspirate (e.g., hip, shoulder, ankle), if needle aspiration fails to adequately drain the joint, if there are loculated effusions, or if osteomyelitis or severe cartilage damage is suspected.
    • Open Surgical Drainage (Arthrotomy): Rarely needed for native joints, typically reserved for cases where arthroscopy is not feasible, severe purulence/fibrin deposition, adjacent osteomyelitis, or failed arthroscopic/needle drainage. Often required for prosthetic joint infections involving specific hardware components.
  • Immobilization: Brief period of splinting for pain relief, followed by early mobilization to prevent stiffness once acute inflammation subsides.
  • Fluid and Electrolyte Management: Address dehydration if fever and poor intake are present.
• Emergency:
  • Sepsis Management: If signs of systemic sepsis are present (hypotension, tachycardia, organ dysfunction), follow sepsis bundles including IV fluids, vasopressors, and close monitoring in an intensive care unit (ICU).
  • Surgical Emergency: Septic arthritis of the hip in children (risk of avascular necrosis of femoral head) or any joint with significant osteomyelitis requires urgent surgical evaluation and drainage.

Chronic Management

• Pharmacological:
  • Targeted Antibiotics: Once culture and sensitivity results are available, narrow the antibiotic spectrum to the most appropriate agent(s) based on susceptibility testing.
  • Duration of Therapy: Typically 2-4 weeks total.
    • Non-gonococcal: Usually 2 weeks IV therapy followed by 2 weeks oral, for a total of 4 weeks. Duration may vary based on response, organism (e.g., staphylococcal infections often require longer treatment), and complications (e.g., osteomyelitis, which requires 6 weeks or more).
    • Gonococcal: Often 7-10 days total. Initial IV ceftriaxone can be switched to oral cefixime 400 mg twice daily or ciprofloxacin 500 mg twice daily once clinical improvement is noted and sensitivity is confirmed.
    • Prosthetic Joint Infections (PJI): Complex, often requires surgical intervention (debridement with retention, one-stage or two-stage exchange arthroplasty) and prolonged antibiotic therapy (e.g., 6 weeks IV/oral combination). Lifelong suppressive oral therapy may be considered in some chronic cases.
  • Oral Step-down: Ensure high oral bioavailability for the chosen agent (e.g., clindamycin, trimethoprim-sulfamethoxazole, fluoroquinolones, linezolid).
• Non-pharmacological:
  • Physical Therapy: Crucial after acute phase for restoring joint function and preventing stiffness. Start gentle passive ROM exercises early, progressing to active exercises and strengthening as tolerated.
  • Joint Protection: Avoid excessive weight-bearing during the healing phase. Crutches, walkers, or splints may be needed.
  • Surgical Interventions:
    • Repeat Drainage: If initial drainage is insufficient or infection recurs.
    • Synovectomy: Rarely needed, but may be considered for chronic proliferative synovitis.
    • Arthroplasty/Arthrodesis: For end-stage joint destruction or failed infection eradication, especially in PJI.
• Monitoring:
  • Clinical Assessment: Regular monitoring for signs of infection resolution (decreased pain, swelling, improved ROM, afebrile).
  • Laboratory Tests: Follow ESR and CRP weekly or every few days initially. Levels should decrease significantly (e.g., CRP half-life is 19 hours). Failure to decline suggests inadequate treatment or complications.
  • Imaging: Repeat X-rays or MRI if there's suspicion of osteomyelitis, persistent symptoms, or to assess for long-term joint damage.

Treatment Algorithms

• First-Line:
  1. Immediate Arthrocentesis: Obtain synovial fluid for analysis (cell count, Gram stain, culture, crystal analysis).
  2. Blood Cultures: Draw at least two sets.
  3. Empiric IV Antibiotics: Immediately after cultures.
     • No Gram Stain Organism / Gram-positive cocci: Vancomycin (for MRSA coverage).
     • Gram-negative bacilli: Ceftriaxone (2g IV daily) or Cefepime (2g IV q8-12h) (if Pseudomonas risk or severely ill).
     • Suspected Gonococcal: Ceftriaxone (1g IV daily) + Azithromycin (1g PO single dose).
     • Polymicrobial / Suspected Anaerobes: Piperacillin-tazobactam or Carbapenem.
  4. Joint Drainage: Daily serial needle aspirations for accessible joints (e.g., knee). Arthroscopic lavage and debridement for difficult joints (e.g., hip, shoulder), loculated effusions, or if needle aspiration fails.
• Second-Line:
  1. Culture-Directed Antibiotics: Once culture and sensitivity results are available, narrow the antibiotic regimen to the most effective and least toxic agent(s).
     • Staphylococcus aureus (MSSA): Nafcillin/Oxacillin (2g IV q4h) or Cefazolin (2g IV q8h).
     • Staphylococcus aureus (MRSA): Vancomycin, Linezolid, or Daptomycin.
     • Streptococci: Penicillin G, Ceftriaxone, or Cefazolin.
     • Gram-negative (e.g., E. coli, Klebsiella): Ceftriaxone, Cefepime, or a fluoroquinolone based on susceptibility.
     • Pseudomonas: Cefepime, Piperacillin-tazobactam, or an aminoglycoside in combination with an anti-pseudomonal beta-lactam.
  2. Continue Drainage: Until joint fluid is sterile and leukocyte count is low.
  3. Transition to Oral Antibiotics: After clinical improvement, afebrile for 24-48 hours, and significant reduction in CRP/ESR, transition to highly bioavailable oral antibiotics for the remainder of the 2-4 week course.
• Refractory Cases:
  1. Re-evaluation: Reassess diagnosis (e.g., missed osteomyelitis, crystal arthritis, non-infectious synovitis).
  2. Imaging: MRI or CT to rule out osteomyelitis, periarticular abscess, or inadequate drainage.
  3. Repeat Cultures: Obtain new joint fluid and blood cultures.
  4. Surgical Intervention: Consider open arthrotomy for thorough debridement, removal of infected synovium, or management of osteomyelitis.
  5. Antibiotic Adjustment: Consider alternative antibiotics, combination therapy, or prolonged duration of therapy based on complex resistance patterns or difficult-to-treat organisms (e.g., fungi, mycobacteria).
  6. PJI: Refractory PJI often requires a two-stage exchange arthroplasty (removal of prosthesis, temporary cement spacer, prolonged antibiotics, then reimplantation).

Complications

• Common:
  • Joint Destruction: Rapid cartilage degradation, leading to degenerative arthritis, pain, and loss of function.
  • Ankylosis: Fibrous or bony fusion of the joint, resulting in permanent loss of movement.
  • Osteomyelitis: Spread of infection to the adjacent bone, requiring prolonged antibiotic treatment and potentially surgical debridement.
  • Recurrent Infection: Due to inadequate drainage or treatment.
• Serious:
  • Sepsis and Septic Shock: Systemic inflammatory response to infection, leading to organ dysfunction, hypotension, and high mortality.
  • Death: Overall mortality rate for non-gonococcal septic arthritis is 5-15%, higher in elderly and immunocompromised patients.
  • Avascular Necrosis: Particularly in the hip joint (e.g., pediatric hip septic arthritis) due to increased intra-articular pressure compromising blood supply.
  • Pathologic Fracture: Weakening of bone due to osteomyelitis or severe inflammation.
• Long-term:
  • Chronic Pain: Persistent joint pain.
  • Loss of Joint Function: Reduced range of motion, weakness, instability.
  • Premature Osteoarthritis: Due to cartilage damage.
  • Limb Length Discrepancy: Especially in children with growth plate involvement.
  • Need for Joint Arthroplasty: If joint destruction is severe.

Prognosis

• Factors:
  • Time to Treatment: Delay in diagnosis and initiation of appropriate antibiotics and drainage is the most significant factor impacting prognosis. Every day of delay increases the risk of irreversible joint damage.
  • Causative Organism: S. aureus infections tend to have worse outcomes than streptococcal or gonococcal infections due to more aggressive cartilage destruction. Gram-negative infections can also be severe.
  • Joint Involved: Hip and shoulder arthritis have worse prognoses than knee arthritis, partially due to difficulty in drainage.
  • Patient Age: Extremes of age (infants and elderly) have worse outcomes.
  • Comorbidities: Immunosuppression, rheumatoid arthritis, diabetes, and other chronic illnesses are associated with higher morbidity and mortality.
  • Prosthetic Joint Involvement: PJI often has a poorer functional outcome and higher risk of requiring further surgery.
  • Adequacy of Drainage: Complete and timely removal of purulent material is crucial.
• Survival:
  • Mortality: Overall mortality for native joint septic arthritis is 5-15%, but can be as high as 30% in elderly or immunocompromised patients, or those with underlying sepsis.
  • Morbidity: Significant residual joint damage and functional impairment occur in 25-50% of survivors.
• Quality of Life:
  • Functional Outcomes: Patients may experience chronic pain, stiffness, limited range of motion, and decreased ability to perform activities of daily living.
  • Need for Further Interventions: Many require long-term physical therapy, assistive devices, or even subsequent joint replacement surgery.

Prevention

• Primary: Preventing initial occurrence.
  • Prompt Treatment of Infections: Timely diagnosis and effective treatment of distant infections (e.g., skin infections, UTIs, endocarditis) to prevent hematogenous spread.
  • Aseptic Technique: Strict adherence to sterile technique during intra-articular injections, arthrocentesis, and surgical procedures involving joints.
  • Hygiene: Good personal hygiene, especially in high-risk groups (e.g., IV drug users).
  • Infection Control: In healthcare settings, minimize risk of nosocomial infections.
  • Safe Sexual Practices: To prevent gonococcal arthritis.
• Secondary: Early detection and intervention.
  • High Index of Suspicion: In patients presenting with acute monoarticular arthritis, especially those with risk factors, prompt diagnostic arthrocentesis is key.
  • Education: Educating high-risk patients (e.g., those with rheumatoid arthritis, prosthetic joints) about symptoms of infection and the importance of seeking early medical attention.
• Tertiary: Preventing complications.
  • Aggressive Management: Rapid initiation of appropriate antibiotics and effective joint drainage.
  • Rehabilitation: Early and structured physical therapy to prevent stiffness and restore function.
  • Monitoring: Close monitoring of clinical and laboratory parameters to ensure infection resolution and detect complications early.

Special Populations

• Pediatric:
  • Common Joints: Hip is frequently affected, especially in neonates and infants. Knee is also common.
  • Organisms: S. aureus remains most common. Kingella kingae (in children <3 years), Group B Streptococcus (in neonates), and Gram-negative organisms (in neonates) are also important.
  • Presentation: Often atypical, including pseudoparalysis, irritability, limping, or refusal to bear weight. Fever may be low-grade or absent.
  • Diagnosis: Arthrocentesis can be challenging, often requiring sedation or ultrasound guidance. CRP and ESR are reliable markers.
  • Treatment: Urgent drainage (especially hip) to prevent avascular necrosis and growth plate damage. Antibiotics typically 3-4 weeks.
• Geriatric:
  • Presentation: Often atypical with less pronounced fever, pain, or leukocytosis. Polyarticular involvement is more common.
  • Risk Factors: High prevalence of comorbidities (diabetes, chronic renal failure, rheumatoid arthritis) and prosthetic joints.
  • Organisms: S. aureus and Gram-negative bacilli are common.
  • Prognosis: Higher morbidity and mortality due to comorbidities, delayed diagnosis, and more aggressive infections.
  • Considerations: Careful antibiotic selection considering renal function and drug interactions. Lower threshold for surgical drainage.
• Pregnancy:
  • Diagnosis: Similar to non-pregnant adults. Imaging should avoid ionizing radiation if possible (ultrasound, MRI preferred over CT/X-ray).
  • Treatment: Antibiotic choice must consider fetal safety. Penicillins, cephalosporins, and clindamycin are generally considered safe. Fluoroquinolones, tetracyclines, and aminoglycosides are generally avoided or used with caution. Joint drainage is critical.
  • Gonococcal Arthritis: More common in pregnancy, requiring prompt treatment with Ceftriaxone.
• Comorbidities:
  • Rheumatoid Arthritis (RA): Polyarticular septic arthritis is more common. Diagnosis can be challenging as symptoms mimic RA flares. Synovial fluid analysis is paramount. S. aureus is the predominant organism. Patients on biologics or immunosuppressants are at higher risk and may have blunted inflammatory responses.
  • Diabetes Mellitus: Increased risk of both Gram-positive and Gram-negative infections. Increased risk of complications (e.g., osteomyelitis, poor wound healing).
  • IV Drug Use: Higher incidence of septic arthritis, often involving atypical joints (sternoclavicular, sacroiliac, vertebral). Pseudomonas aeruginosa and polymicrobial infections are more common. Endocarditis should be ruled out.
  • Prosthetic Joint Infection (PJI): Specific diagnostic algorithms (e.g., MSIS criteria). Requires prolonged, often combination, antibiotics and almost always surgical intervention (debridement with retention, one-stage, or two-stage exchange arthroplasty). Organisms often include coagulase-negative staphylococci, S. aureus, and Gram-negative bacilli.

Clinical Pearls

• Diagnostic:
  • "Hot, swollen joint" is septic until proven otherwise. The most important diagnostic step is urgent arthrocentesis. Do not delay.
  • Synovial Fluid Analysis is Key. Even if blood cultures are negative and systemic inflammatory markers are mildly elevated, a synovial fluid WBC count >50,000 cells/mm³ with >75% PMNs strongly suggests septic arthritis.
  • Crystal and Infection Co-exist. Always check for crystals in synovial fluid, as crystal-induced arthritis (gout, pseudogout) can predispose to or co-exist with septic arthritis.
  • Negative Gram Stain Does Not Rule Out Infection. Up to 50% of synovial fluid Gram stains are negative, especially with streptococci or gonococci. Start empiric antibiotics regardless.
  • Think Atypical Joints in IVDU. Always consider sternoclavicular, sacroiliac, or spinal joint involvement in intravenous drug users.
• Treatment:
  • Time is Tissue. Every hour of delay in starting appropriate antibiotics and ensuring adequate joint drainage can lead to irreversible cartilage damage.
  • Drainage is as Important as Antibiotics. Antibiotics cannot penetrate purulent, avascular debris effectively. Adequate drainage is paramount.
  • Empiric Antibiotics Are Crucial. Start broad-spectrum antibiotics after obtaining cultures, but before culture results are available.
  • Adjust and Narrow. Once culture and sensitivity results are available, de-escalate antibiotics to the narrowest effective agent.
  • IV to Oral Step-down. Transition to oral antibiotics is appropriate once clinically stable, afebrile, and inflammatory markers are trending down, using agents with good oral bioavailability.
  • Early Mobilization Post-Drainage. Immobilize briefly for pain, then start gentle range of motion exercises to prevent stiffness and aid recovery.
• Pitfalls:
  • Delaying Arthrocentesis: Waiting for blood work, X-rays, or orthopedic consultation.
  • Missing Atypical Presentations: Especially in children, elderly, or immunocompromised patients where classical signs may be absent.
  • Inadequate Drainage: Not ensuring complete removal of purulent material, leading to persistent infection.
  • Stopping Antibiotics Too Soon: Leading to recurrence or chronic complications.
  • Overlooking Co-existing Conditions: Such as crystal arthritis, osteomyelitis, or prosthetic joint infection.
  • Misinterpreting Synovial Fluid in RA: Rheumatoid joints can have very high synovial fluid WBC counts (e.g., >20,000 cells/mm³) in a flare. Always prioritize culture and Gram stain in these cases.

Recent Updates

• Guidelines:
  • Updated guidelines (e.g., IDSA, EULAR) emphasize rapid diagnosis and management algorithms.
  • Increased focus on differentiating native joint infection from prosthetic joint infection with distinct diagnostic criteria and treatment pathways.
  • Guidance on optimal duration of therapy and criteria for IV to oral step-down.
• Evidence:
  • Growing evidence supports the role of intra-articular antibiotics as an adjunct to systemic therapy, particularly in difficult-to-treat infections or those involving biofilms (e.g., PJI), though not routinely recommended for native joints.
  • Emergence of rapid diagnostic tests (e.g., multiplex PCR for synovial fluid, MALDI-TOF MS for culture identification) can reduce turnaround time for pathogen identification, potentially allowing earlier de-escalation of empiric therapy.
  • Refined understanding of inflammatory markers (e.g., procalcitonin) in differentiating bacterial from non-bacterial joint inflammation, although synovial fluid analysis remains paramount.
  • Increased understanding of biofilm formation in PJI and the rationale for aggressive surgical debridement.
• Controversies:
  • Optimal Drainage Method: Debate continues regarding the superiority of serial needle aspiration vs. arthroscopic lavage for all native joints. Most agree arthroscopy is better for hip/shoulder and for failed aspirations.
  • Role of Intra-articular Antibiotics: While not standard for native joints, their utility in specific difficult cases or PJI remains an area of research.
  • Antibiotic Duration: Exact duration of IV vs. oral therapy and total duration can vary, particularly for difficult-to-treat organisms or immunocompromised patients.
  • Management of Culture-Negative Septic Arthritis: When clinical suspicion is high but cultures are persistently negative, management strategies can be challenging and often require prolonged empiric therapy and re-evaluation.

Key References

• Guidelines:
  • Infectious Diseases Society of America (IDSA): Clinical Practice Guidelines for the Diagnosis and Management of Prosthetic Joint Infection (2012, updates pending). While focused on PJI, general principles of management are often discussed.
  • European League Against Rheumatism (EULAR): Recommendations for the management of septic arthritis in adults (2017).
  • American Academy of Orthopaedic Surgeons (AAOS): Guidelines for the Diagnosis and Treatment of Periprosthetic Joint Infection.
• Studies:
  • Kaandorp et al. (2001): The outcome of septic arthritis in rheumatoid arthritis. Arthritis Rheum. This and similar studies highlight the unique challenges and worse prognosis in RA patients.
  • Goldenberg and Reed (2000): Bacterial Arthritis. N Engl J Med. A classic review covering general principles.
  • Numerous studies on antibiotic efficacy, surgical techniques, and diagnostic accuracy in various journals like Clinical Infectious Diseases, Journal of Bone and Joint Surgery, Annals of the Rheumatic Diseases.
• Reviews:
  • Mathews, C. J., et al. (2010). Septic arthritis: current diagnostic and therapeutic algorithm. Current Opinion in Rheumatology.
  • Pääkkönen, M., & Peltola, H. (2013). Acute osteomyelitis and septic arthritis in children. Current Opinion in Pediatrics.
  • Mani, A., & Bakhshi, S. (2020). Septic Arthritis. StatPearls. Available via NCBI Bookshelf.